Overview

BReast CAncer Genes(BRCA) Expressions in Metastatic Gastric Cancer

Status:
Completed
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
The investigators evaluated the incidence of BRCA loss in patients with advanced gastric cancer and observed the treatment outcome and prognosis according to BRCA loss. And the investigators evaluated the possibility of BRCA loss as a predictive and prognostic factor.
Phase:
N/A
Details
Lead Sponsor:
Chung-Ang University
Treatments:
Capecitabine
Oxaliplatin